newsfilter
← Latest News
GlobeNewswire·

Instil Bio Reports Second Quarter 2023 Financial Results and Provides Corporate Update

ITIL-306, first CoStAR-TIL in clinical development, anticipated to start clinical trial ITIL-306-202 in 2H 2023 Initial data from ITIL-306-202 clinical trial anticipated in 2024 ITIL-306 operational in Manchester, UK